Gallacher Capital Management LLC Buys New Position in The Clorox Company (NYSE:CLX)

Gallacher Capital Management LLC purchased a new stake in The Clorox Company (NYSE:CLX - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 2,961 shares of the company's stock, valued at approximately $436,000.

Several other large investors have also bought and sold shares of CLX. Redwood Park Advisors LLC bought a new stake in shares of Clorox during the 4th quarter worth $26,000. Millstone Evans Group LLC bought a new stake in shares of Clorox during the 4th quarter worth $31,000. Wood Tarver Financial Group LLC bought a new stake in shares of Clorox during the 4th quarter worth $31,000. GKV Capital Management Co. Inc. bought a new stake in shares of Clorox during the 4th quarter worth $32,000. Finally, Aster Capital Management DIFC Ltd bought a new stake in shares of Clorox during the 4th quarter worth $33,000. 78.53% of the stock is currently owned by institutional investors.

Clorox Price Performance

CLX traded down $0.04 during midday trading on Thursday, hitting $131.40. The stock had a trading volume of 630,157 shares, compared to its average volume of 1,595,013. The company has a market cap of $16.19 billion, a P/E ratio of 23.60, a price-to-earnings-growth ratio of 3.41 and a beta of 0.51. The business has a fifty day moving average of $126.95 and a 200 day moving average of $140.67. The company has a debt-to-equity ratio of 13.07, a quick ratio of 0.44 and a current ratio of 0.74. The Clorox Company has a 1 year low of $117.35 and a 1 year high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.57 by ($0.12). The firm had revenue of $1.67 billion during the quarter, compared to analysts' expectations of $1.74 billion. Clorox had a return on equity of 324.23% and a net margin of 9.89%. The firm's quarterly revenue was down 8.0% compared to the same quarter last year. During the same period in the prior year, the company earned $1.71 EPS. As a group, equities analysts forecast that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have recently commented on CLX. Wells Fargo & Company lowered their target price on Clorox from $142.00 to $135.00 and set an "equal weight" rating on the stock in a research note on Wednesday, July 9th. Barclays set a $119.00 price objective on Clorox and gave the company an "underweight" rating in a research note on Tuesday, July 15th. JPMorgan Chase & Co. lowered their price objective on Clorox from $151.00 to $144.00 and set a "neutral" rating on the stock in a research note on Tuesday, May 6th. UBS Group lowered their price objective on Clorox from $150.00 to $134.00 and set a "neutral" rating on the stock in a research note on Thursday, July 17th. Finally, Evercore ISI set a $140.00 price target on Clorox and gave the company an "underperform" rating in a research report on Tuesday, May 6th. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Hold" and an average target price of $145.17.

Insider Transactions at Clorox

In related news, Director Pierre R. Breber acquired 4,000 shares of the stock in a transaction on Wednesday, May 7th. The stock was purchased at an average price of $136.57 per share, for a total transaction of $546,280.00. Following the completion of the transaction, the director owned 4,000 shares of the company's stock, valued at $546,280. This trade represents a ∞ increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.57% of the stock is currently owned by corporate insiders.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.